Hepatitis D virus (HDV) infection affects more than 10 million people worldwide, with an estimated prevalence of nearly 4.5% among HBsAg-positive individuals. Epidemiological studies have shown a significant increase in the prevalence of hepatocel-lular carcinoma (HCC) in patients with chronic HDV infection compared to those with chronic hepatitis B virus (HBV) mono-infection. Despite the clinical findings, data on molecular oncogenic mechanisms are limited and fragmentary. Moreover, the role of HDV in promoting the development of HCC has so far been controversial, because it is difficult to weigh the respective contributions of the two viruses. In this review, we focused on the direct oncogenic action of HDV, its role in modifying the tumor microenviron-ment, and the genetic signature of HDV-related HCC, comparing these features with HBV-related HCC.
CITATION STYLE
Costante, F., Stella, L., Santopaolo, F., Gasbarrini, A., Pompili, M., Asselah, T., & Ponziani, F. R. (2023). Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma. Dove Medical Press Ltd. https://doi.org/10.2147/JHC.S384751
Mendeley helps you to discover research relevant for your work.